Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

Browse up-to-the-minute automotive news and analysis, including expert reviews of the latest cars on the market, at Cars.com.